Evidence map›Paper›PMID 41635668›Full record

ArticleActa clinica Croatica2025

CLEAR CELL VARIANT OF AMELOBLASTIC CARCINOMA OF THE MAXILLA: A CASE REPORT AND REVIEW OF DIFFERENTIAL DIAGNOSTIC AND THERAPEUTIC APPROACH.

Luka Manojlović, Daniel Jerković, Davor Brajdić, Predrag Knežević, Spomenka Manojlović

Abstract readCase Reports
In one paragraph

Article in Acta clinica Croatica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Luka Manojlović
Daniel Jerković
Davor BrajdićSchool of Dentistry, University of Zagreb, Zagreb, Croatia.
Predrag KneževićSchool of Dentistry, University of Zagreb, Zagreb, Croatia.
Spomenka ManojlovićSchool of Medicine, University of Zagreb, Zagreb, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ameloblastic carcinoma is a rare malignant epithelial tumor, mostly affecting the mandible. Maxillary ameloblastic carcinoma is even more uncommon and its clear cell variant has been exceedingly rarely described. Because clear cell lesions of jaw bones are both rare and diagnostically challenging, the incidence of the tumor, as well as the criteria for classification are not precisely defined. Differential diagnosis includes a variety of benign or malignant tumors of odontogenic and salivary gland origin, as well as metastatic tumors. Diagnostic dilemma extends to therapeutic approach. Treatment modalities are still debated. The present case report discusses the clinical and histologic differential diagnosis of clear cell variant of an aggressive maxillary ameloblastic carcinoma which was successfully treated with preoperative radiation therapy, followed by surgical excision of the residual lesion and reconstruction of the maxilla.

Indexed as

AmeloblasticCarcinomaClear-cellOdontogenicPathologyRadiotherapy

Identifiers

PMID41635668
PMCPMC12863288

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.